Cedars-Sinai Discovery May Aid Doctors in Diagnosing At-risk Patients Before Symptoms Appear
A team led by a Cedars-Sinai physician-scientist has discovered a biomarker—a protein found in the blood—for the most common type of heart failure, a new study published today in JAMA Cardiology shows.
Heart failure with preserved ejection fraction (HFpEF) affects more than 6.5 million Americans each year. And now, thanks to the discovery of the first-ever biomarker for HFpEF, a simple blood test can reveal whether a patient’s heart is not making enough of an important protein. If the protein levels are decreased, the biomarker signal increases and physicians will be able to diagnose heart failure sooner, prescribe corrective medicines and prevent further disease progression.
“By the time heart failure symptoms develop, the critical window for corrective therapy has typically closed,” said Robin Shaw, MD, PhD, the Wasserman Endowed Chair in Cardiology and professor of Medicine at the Smidt Heart Institute at Cedars-Sinai and principal investigator on the study. “Our discovery allows us to not only diagnose the disease sooner, but also to treat patients before that critical period of early intervention for lifesaving care has closed.”
Heart failure with preserved ejection fraction is a condition where the heart can contract, but has problems relaxing—limiting the heart’s ability to fill with blood between each beat—and therefore lowers the amount of blood moving forward with each contraction. Prior to the discovery of the biomarker, clinicians had to wait for patients to have symptoms to make a diagnosis of HFpEF and had to use an echocardiogram that measured how well the heart relaxed. There was no method to gauge the health of the heart muscle before symptoms developed or determine the severity of disease once symptoms were present.
The biomarker—named cBIN1 Score, or CS for short—allows doctors to measure muscle deterioration and measure a protein that regulates the heart’s ability to both contract and relax. As the protein decreases, CS increases, serving as an indication of onset heart failure. The CS biomarker can be measured using a simple blood draw.
This discovery will allow the most at-risk patients—including older patients and patients with high blood pressure, diabetes or dyslipidemia—to be checked during an annual exam from their primary care physician. This pivotal research has the potential to impact millions of people and serve as a critical tool for preventive heart care.
Eduardo Marbán, MD, PhD, director, Smidt Heart Institute
The CS biomarker is designed to be used in an outpatient clinic setting. For patients with known HFpEF, doctors can draw a CS level and use it to both guide current care, including medication adjustments, and predict the chances of a patient being admitted to the hospital in the next 12 months.
“More broadly, this discovery will allow the most at-risk patients—including older patients and patients with high blood pressure, diabetes or dyslipidemia—to be checked during an annual exam from their primary care physician,” said Eduardo Marbán, MD, PhD, director of the Smidt Heart Institute. “This pivotal research has the potential to impact millions of people and serve as a critical tool for preventive heart care.”
Symptoms of heart failure typically appear as fatigue, fluid weight gain, leg swelling and shortness of breath. Heart failure with preserved ejection fraction is typically diagnosed in elderly people or those living with high blood pressure, diabetes, elevated cholesterol, hypertension, obesity, obstructive sleep apnea, anemia, iron deficiency or diabetes. Its prevalence is projected to rise drastically over the coming decades. Previous studies have shown that women represent the majority of patients diagnosed with the disease.
As next steps, Cedars-Sinai researchers plan on identifying specialty populations in which the CS biomarker could be useful, including sex-based differences, those who have undergone a heart transplant or valve replacement, as well as individuals with no known heart disease or risk factors.
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- St. Mary’s Regional Heart Institute leading the fi ght against Cardiovascular Diseaseon March 22, 2020 at 11:55 am
Highly specialized cardiovascular services are greatly needed in our community as heart disease is the No. 1 killer among adults. For more than 40 years, St. Mary’s Medical Center has been a ...
- Mental Stress May Predict 2nd Heart Attack or Dying from Heart Diseaseon March 22, 2020 at 8:47 am
For some people who survive a heart attack, mental stress may be a stronger predictor of a repeat heart attack or dying from heart disease than physical stress, according to new research. Traditional ...
- Heart disease risk undertreated among noncitizens, study sayson March 20, 2020 at 7:24 am
Foreign nationals in the United States are less likely to receive treatment for heart disease risk factors than native-born Americans or naturalized citizens, a new study reports. Heart disease -- ...
- Coronavirus is especially threatening for people with heart diseaseon March 20, 2020 at 5:08 am
As the novel coronavirus spreads around the world, it primarily sickens people by affecting their lungs. But it is now becoming clear that the finishing blow for people who don’t survive might be to ...
- Statins During Cancer Tx Linked to Fewer Later Heart Failure Eventson March 19, 2020 at 7:35 am
With a rate of about 4%, people prescribed a statin while on anthracyclines had a lower risk of hospitalization or emergency department visits for heart failure over 10 years than among matched peers ...
- Olive oil may lower heart disease riskon March 19, 2020 at 6:12 am
Health experts have urged consumers to consider swapping butter and margarine for olive oil in their cooking. A staple of Mediterranean diets, olive oil is considered to be a superfood as it is rich ...
- Inflammatory Heart Disease Market Current Scenario and Trends to (2020-2026)on March 19, 2020 at 3:25 am
Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various ...
- Congenital Heart Disease Market With Robust CAGR in Forecast Period 2020 to 2026on March 19, 2020 at 2:21 am
A congenital heart disease is a problem in the structure of the heart that is present at birth. The factors driving the growth of the global congenital heart disease market are rising prevalence of ...
- Having a low birthweight baby may increase risk for early heart failureon March 18, 2020 at 8:15 am
20/WCC), suggests that giving birth to a baby under 5.5 pounds may be an independent risk factor for developing changes in heart function that can lead to heart failure, a condition in which the heart ...
via Bing News